{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:56:55Z","timestamp":1792663015134,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41575-024-00895-3","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:02:45Z","timestamp":1707490965000},"page":"335-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Tolerance-inducing therapies in coeliac disease \u2014 mechanisms, progress and future directions"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-704X","authenticated-orcid":false,"given":"Ludvig M.","family":"Sollid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"895_CR1","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1136\/gutjnl-2021-326257","volume":"71","author":"A Levescot","year":"2022","unstructured":"Levescot, A., Malamut, G. & Cerf-Bensussan, N. Immunopathogenesis and environmental triggers in coeliac disease. Gut 71, 2337\u20132349 (2022).","journal-title":"Gut"},{"key":"895_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathmechdis-031521-032634","volume":"18","author":"R Iversen","year":"2023","unstructured":"Iversen, R. & Sollid, L. M. The immunobiology and pathogenesis of celiac disease. Annu. Rev. Pathol. 18, 47\u201370 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"895_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/apt.16787","volume":"56","author":"GK Makharia","year":"2022","unstructured":"Makharia, G. K., Chauhan, A., Singh, P. & Ahuja, V. Review article: epidemiology of coeliac disease. Aliment. Pharmacol. Ther. 56, S3\u2013S17 (2022).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"895_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"B Lebwohl","year":"2018","unstructured":"Lebwohl, B., Sanders, D. S. & Green, P. H. R. Coeliac disease. Lancet 391, 70\u201381 (2018).","journal-title":"Lancet"},{"key":"895_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/jhn.12316","volume":"29","author":"JA Silvester","year":"2016","unstructured":"Silvester, J. A., Weiten, D., Graff, L. A., Walker, J. R. & Duerksen, D. R. Living gluten-free: adherence, knowledge, lifestyle adaptations and feelings towards a gluten-free diet. J. Hum. Nutr. Diet. 29, 374\u2013382 (2016).","journal-title":"J. Hum. Nutr. Diet."},{"key":"895_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/apt.16075","volume":"52","author":"JA Silvester","year":"2020","unstructured":"Silvester, J. A. et al. Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet. Aliment. Pharmacol. Ther. 52, 1469\u20131479 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"895_CR7","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3748\/wjg.v27.i20.2603","volume":"27","author":"KE Lundin","year":"2021","unstructured":"Lundin, K. E. et al. Understanding celiac disease monitoring patterns and outcomes after diagnosis: a multinational, retrospective chart review study. World J. Gastroenterol. 27, 2603\u20132614 (2021).","journal-title":"World J. Gastroenterol."},{"key":"895_CR8","doi-asserted-by":"publisher","unstructured":"Patel, N. et al. Clinical data do not reliably predict duodenal histology at follow-up in celiac disease: a 13 center correlative study. Am. J. Surg. Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000002150 (2023).","DOI":"10.1097\/PAS.0000000000002150"},{"key":"895_CR9","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1016\/j.cgh.2021.08.046","volume":"20","author":"D De Leon Morilla","year":"2022","unstructured":"De Leon Morilla, D. et al. Patients\u2019 risk tolerance for non-dietary therapies in celiac disease. Clin. Gastroenterol. Hepatol. 20, 2647\u20132649 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"895_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41575-021-00511-8","volume":"18","author":"MI Pinto-Sanchez","year":"2021","unstructured":"Pinto-Sanchez, M. I. et al. Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease. Nat. Rev. Gastroenterol. Hepatol. 18, 875\u2013884 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"895_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/1744666X.2021.2006636","volume":"18","author":"RP Anderson","year":"2022","unstructured":"Anderson, R. P. Emergence of an adaptive immune paradigm to explain celiac disease: a perspective on new evidence and implications for future interventions and diagnosis. Expert Rev. Clin. Immunol. 18, 75\u201391 (2022).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"895_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","volume":"18","author":"L Kivel\u00e4","year":"2021","unstructured":"Kivel\u00e4, L. et al. Current and emerging therapies for coeliac disease. Nat. Rev. Gastroenterol. Hepatol. 18, 181\u2013195 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"895_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0016-5085(60)80115-1","volume":"38","author":"CE Rubin","year":"1960","unstructured":"Rubin, C. E., Brandborg, L. L., Phelps, P. C. & Taylor, H. C. Studies of celiac disease. I. Apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology 38, 28\u201349 (1960).","journal-title":"Gastroenterology"},{"key":"895_CR14","unstructured":"Marsh, M. N. in Coeliac Disease (ed. Marsh, M. N.) 136\u2013191 (Blackwell Scientific Publications, 1992)."},{"key":"895_CR15","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/gut.12.12.988","volume":"12","author":"A Ferguson","year":"1971","unstructured":"Ferguson, A. & Murray, D. Quantitation of intraepithelial lymphocytes in human jejunum. Gut 12, 988\u2013994 (1971).","journal-title":"Gut"},{"key":"895_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41385-018-0016-5","volume":"11","author":"T Mayassi","year":"2018","unstructured":"Mayassi, T. & Jabri, B. Human intraepithelial lymphocytes. Mucosal Immunol. 11, 1281\u20131289 (2018).","journal-title":"Mucosal Immunol."},{"key":"895_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0016-5085(00)70173-9","volume":"118","author":"B Jabri","year":"2000","unstructured":"Jabri, B. et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118, 867\u2013879 (2000).","journal-title":"Gastroenterology"},{"key":"895_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","volume":"21","author":"S H\u00fce","year":"2004","unstructured":"H\u00fce, S. et al. A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367\u2013377 (2004).","journal-title":"Immunity"},{"key":"895_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","volume":"21","author":"B Meresse","year":"2004","unstructured":"Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357\u2013366 (2004).","journal-title":"Immunity"},{"key":"895_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/00365521.1977.12031127","volume":"12","author":"K Baklien","year":"1977","unstructured":"Baklien, K., Brandtzaeg, P. & Fausa, O. Immunoglobulins in jejunal mucosa and serum from patients with adult coeliac disease. Scand. J. Gastroenterol. 12, 149\u2013159 (1977).","journal-title":"Scand. J. Gastroenterol."},{"key":"895_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","volume":"102","author":"MN Marsh","year":"1992","unstructured":"Marsh, M. N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u2018celiac sprue\u2019). Gastroenterology 102, 330\u2013354 (1992).","journal-title":"Gastroenterology"},{"key":"895_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/mi.2016.59","volume":"9","author":"J Spencer","year":"2016","unstructured":"Spencer, J. & Sollid, L. M. The human intestinal B-cell response. Mucosal Immunol. 9, 1113\u20131124 (2016).","journal-title":"Mucosal Immunol."},{"key":"895_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2020.02.001","volume":"52","author":"TM Fenton","year":"2020","unstructured":"Fenton, T. M. et al. Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in priming of region-specific immunity. Immunity 52, 557\u2013570.e6 (2020).","journal-title":"Immunity"},{"key":"895_CR24","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1084\/jem.20190414","volume":"216","author":"R Bartolome-Casado","year":"2019","unstructured":"Bartolome-Casado, R. et al. Resident memory CD8 T cells persist for years in human small intestine. J. Exp. Med. 216, 2412\u20132426 (2019).","journal-title":"J. Exp. Med."},{"key":"895_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41385-020-0315-5","volume":"14","author":"R Bartolome-Casado","year":"2021","unstructured":"Bartolome-Casado, R. et al. CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profile. Mucosal Immunol. 14, 402\u2013410 (2021).","journal-title":"Mucosal Immunol."},{"key":"895_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1084\/jem.20161590","volume":"214","author":"OJ Landsverk","year":"2017","unstructured":"Landsverk, O. J. et al. Antibody-secreting plasma cells persist for decades in human intestine. J. Exp. Med. 214, 309\u2013317 (2017).","journal-title":"J. Exp. Med."},{"key":"895_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/gut.2005.083964","volume":"55","author":"L Nistico","year":"2006","unstructured":"Nistico, L. et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55, 803\u2013808 (2006).","journal-title":"Gut"},{"key":"895_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.998","volume":"43","author":"G Trynka","year":"2011","unstructured":"Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193\u20131201 (2011).","journal-title":"Nat. Genet."},{"key":"895_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00251-017-0985-7","volume":"69","author":"LM Sollid","year":"2017","unstructured":"Sollid, L. M. The roles of MHC class II genes and post-translational modification in celiac disease. Immunogenetics 69, 605\u2013616 (2017).","journal-title":"Immunogenetics"},{"key":"895_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki, V., Kumar, V., Wijmenga, C. & Zhernakova, A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 18, 76 (2017).","journal-title":"Genome Biol."},{"key":"895_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1084\/jem.178.1.187","volume":"178","author":"KEA Lundin","year":"1993","unstructured":"Lundin, K. E. A. et al. Gliadin-specific, HLA-DQ(\u03b11*0501,\u03b21*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187\u2013196 (1993).","journal-title":"J. Exp. Med."},{"key":"895_CR32","doi-asserted-by":"publisher","first-page":"10050","DOI":"10.1073\/pnas.95.17.10050","volume":"95","author":"Y van de Wal","year":"1998","unstructured":"van de Wal, Y. et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl Acad. Sci. USA 95, 10050\u201310054 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"895_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0198-8859(94)90047-7","volume":"41","author":"KEA Lundin","year":"1994","unstructured":"Lundin, K. E. A., Scott, H., Fausa, O., Thorsby, E. & Sollid, L. M. T cells from the small intestinal mucosa of a DR4, DQ7\/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum. Immunol. 41, 285\u2013291 (1994).","journal-title":"Hum. Immunol."},{"key":"895_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1365-3083.1998.00397.x","volume":"48","author":"H Sj\u00f6str\u00f6m","year":"1998","unstructured":"Sj\u00f6str\u00f6m, H. et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol. 48, 111\u2013115 (1998).","journal-title":"Scand. J. Immunol."},{"key":"895_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00251-019-01141-w","volume":"72","author":"LM Sollid","year":"2020","unstructured":"Sollid, L. M. et al. Update 2020: nomenclature and listing of celiac disease-relevant gluten epitopes recognized by CD4+ T cells. Immunogenetics 72, 85\u201388 (2020).","journal-title":"Immunogenetics"},{"key":"895_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/j.gastro.2017.05.016","volume":"153","author":"M R\u00e1ki","year":"2017","unstructured":"R\u00e1ki, M. et al. Similar responses of intestinal T cells from untreated children and adults with celiac disease to deamidated gluten epitopes. Gastroenterology 153, 787\u2013798.e4 (2017).","journal-title":"Gastroenterology"},{"key":"895_CR37","doi-asserted-by":"publisher","first-page":"646163","DOI":"10.3389\/fimmu.2021.646163","volume":"12","author":"SW Qiao","year":"2021","unstructured":"Qiao, S. W., Dahal-Koirala, S., Eggesbo, L. M., Lundin, K. E. A. & Sollid, L. M. Frequency of gluten-reactive T cells in active celiac lesions estimated by direct cell cloning. Front. Immunol. 12, 646163 (2021).","journal-title":"Front. Immunol."},{"key":"895_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/2050640614540154","volume":"2","author":"A Christophersen","year":"2014","unstructured":"Christophersen, A. et al. Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. United European Gastroenterol. J. 2, 268\u2013278 (2014).","journal-title":"United European Gastroenterol. J."},{"key":"895_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41591-019-0403-9","volume":"25","author":"A Christophersen","year":"2019","unstructured":"Christophersen, A. et al. Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions. Nat. Med. 25, 734\u2013737 (2019).","journal-title":"Nat. Med."},{"key":"895_CR40","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/eji.201343382","volume":"43","author":"M Bodd","year":"2013","unstructured":"Bodd, M. et al. Direct cloning and tetramer staining to measure the frequency of intestinal gluten-reactive T cells in celiac disease. Eur. J. Immunol. 43, 2605\u20132612 (2013).","journal-title":"Eur. J. Immunol."},{"key":"895_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cei.13578","volume":"204","author":"RP Anderson","year":"2021","unstructured":"Anderson, R. P. et al. Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease. Clin. Exp. Immunol. 204, 321\u2013334 (2021).","journal-title":"Clin. Exp. Immunol."},{"key":"895_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3, 797\u2013801 (1997).","journal-title":"Nat. Med."},{"key":"895_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nm0698-713","volume":"4","author":"\u00d8 Molberg","year":"1998","unstructured":"Molberg, \u00d8. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4, 713\u2013717 (1998).","journal-title":"Nat. Med."},{"key":"895_CR44","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.4049\/jimmunol.161.4.1585","volume":"161","author":"Y van de Wal","year":"1998","unstructured":"van de Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161, 1585\u20131588 (1998).","journal-title":"J. Immunol."},{"key":"895_CR45","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/gut.41.6.851","volume":"41","author":"LM Sollid","year":"1997","unstructured":"Sollid, L. M., Molberg, \u00d8., McAdam, S. & Lundin, K. E. Autoantibodies in coeliac disease: tissue transglutaminase \u2014 guilt by association? Gut 41, 851\u2013852 (1997).","journal-title":"Gut"},{"key":"895_CR46","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1053\/j.gastro.2020.04.018","volume":"159","author":"R Iversen","year":"2020","unstructured":"Iversen, R. et al. Evidence that pathogenic transglutaminase 2 in celiac disease derives from enterocytes. Gastroenterology 159, 788\u2013790 (2020).","journal-title":"Gastroenterology"},{"key":"895_CR47","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1053\/j.gastro.2005.02.028","volume":"128","author":"A Rostom","year":"2005","unstructured":"Rostom, A. et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128, S38\u2013S46 (2005).","journal-title":"Gastroenterology"},{"key":"895_CR48","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S0016-5085(98)70008-3","volume":"115","author":"S Sulkanen","year":"1998","unstructured":"Sulkanen, S. et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115, 1322\u20131328 (1998).","journal-title":"Gastroenterology"},{"key":"895_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/gut.42.3.362","volume":"42","author":"F Cataldo","year":"1998","unstructured":"Cataldo, F., Marino, V., Ventura, A., Bottaro, G. & Corazza, G. R. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and \u201cClub del Tenue\u201d Working Groups on Coeliac Disease. Gut 42, 362\u2013365 (1998).","journal-title":"Gut"},{"key":"895_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coi.2014.08.005","volume":"31","author":"LM Sollid","year":"2014","unstructured":"Sollid, L. M., Pos, W. & Wucherpfennig, K. W. Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. Curr. Opin. Immunol. 31, 24\u201330 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"895_CR51","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.jaci.2017.02.015","volume":"140","author":"L Cook","year":"2017","unstructured":"Cook, L. et al. Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease. J. Allergy Clin. Immunol. 140, 1592\u20131603.e8 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"895_CR52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jaci.2023.02.030","volume":"152","author":"SK Chauhan","year":"2023","unstructured":"Chauhan, S. K. et al. Human small intestine contains 2 functionally distinct regulatory T-cell subsets. J. Allergy Clin. Immunol. 152, 278\u2013289.e6 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"895_CR53","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1172\/JCI200421055","volume":"114","author":"E Marietta","year":"2004","unstructured":"Marietta, E. et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest. 114, 1090\u20131097 (2004).","journal-title":"J. Clin. Invest."},{"key":"895_CR54","doi-asserted-by":"publisher","first-page":"7440","DOI":"10.4049\/jimmunol.0900233","volume":"182","author":"AL de Kauwe","year":"2009","unstructured":"de Kauwe, A. L. et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182, 7440\u20137450 (2009).","journal-title":"J. Immunol."},{"key":"895_CR55","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1136\/gut.2009.186361","volume":"58","author":"TL Freitag","year":"2009","unstructured":"Freitag, T. L. et al. Gliadin-primed CD4+CD45RBlowCD25\u2212 T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice. Gut 58, 1597\u20131605 (2009).","journal-title":"Gut"},{"key":"895_CR56","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.4049\/jimmunol.1100854","volume":"187","author":"HJ Galipeau","year":"2011","unstructured":"Galipeau, H. J. et al. Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J. Immunol. 187, 4338\u20134346 (2011).","journal-title":"J. Immunol."},{"key":"895_CR57","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","volume":"578","author":"V Abadie","year":"2020","unstructured":"Abadie, V. et al. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease. Nature 578, 600\u2013604 (2020).","journal-title":"Nature"},{"key":"895_CR58","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0091-6749(98)70402-6","volume":"101","author":"U Muller","year":"1998","unstructured":"Muller, U. et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. 101, 747\u2013754 (1998).","journal-title":"J. Allergy Clin. Immunol."},{"key":"895_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jaci.2012.07.028","volume":"131","author":"D Patel","year":"2013","unstructured":"Patel, D. et al. Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study. J. Allergy Clin. Immunol. 131, 103\u2013109.e7 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"895_CR60","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","volume":"379","author":"Palisade Group of Clinical Investigators.","year":"2018","unstructured":"Palisade Group of Clinical Investigators. AR101 oral immunotherapy for peanut allergy. N. Engl. J. Med. 379, 1991\u20132001 (2018).","journal-title":"N. Engl. J. Med."},{"key":"895_CR61","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","volume":"177","author":"L Noon","year":"1911","unstructured":"Noon, L. Prophylactic inoculation against hay fever. Lancet 177, 1572\u20131573 (1911).","journal-title":"Lancet"},{"key":"895_CR62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","volume":"23","author":"SR Durham","year":"2023","unstructured":"Durham, S. R. & Shamji, M. H. Allergen immunotherapy: past, present and future. Nat. Rev. Immunol. 23, 317\u2013328 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"895_CR63","doi-asserted-by":"publisher","first-page":"ltab009","DOI":"10.1093\/immadv\/ltab009","volume":"1","author":"N Richardson","year":"2021","unstructured":"Richardson, N. & Wraith, D. C. Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity. Immunother. Adv. 1, ltab009 (2021).","journal-title":"Immunother. Adv."},{"key":"895_CR64","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.coi.2010.08.002","volume":"22","author":"AR Kendal","year":"2010","unstructured":"Kendal, A. R. & Waldmann, H. Infectious tolerance: therapeutic potential. Curr. Opin. Immunol. 22, 560\u2013565 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"895_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","volume":"54","author":"CA Janeway Jr.","year":"1989","unstructured":"Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1\u201313 (1989).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"895_CR66","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1073\/pnas.90.14.6586","volume":"90","author":"CD Gimmi","year":"1993","unstructured":"Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. & Nadler, L. M. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl Acad. Sci. USA 90, 6586\u20136590 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"895_CR67","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/eji.200635883","volume":"36","author":"PO Anderson","year":"2006","unstructured":"Anderson, P. O. et al. Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur. J. Immunol. 36, 1374\u20131385 (2006).","journal-title":"Eur. J. Immunol."},{"key":"895_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5741","volume":"5","author":"BR Burton","year":"2014","unstructured":"Burton, B. R. et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat. Commun. 5, 4741 (2014).","journal-title":"Nat. Commun."},{"key":"895_CR69","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1084\/jem.20082118","volume":"206","author":"L Gabry\u0161ov\u00e1","year":"2009","unstructured":"Gabry\u0161ov\u00e1, L. et al. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 206, 1755\u20131767 (2009).","journal-title":"J. Exp. Med."},{"key":"895_CR70","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434\u2013440 (2016).","journal-title":"Nature"},{"key":"895_CR71","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.4049\/jimmunol.170.3.1240","volume":"170","author":"A Sundstedt","year":"2003","unstructured":"Sundstedt, A., O\u2019Neill, E. J., Nicolson, K. S. & Wraith, D. C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170, 1240\u20131248 (2003).","journal-title":"J. Immunol."},{"key":"895_CR72","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/j.gastro.2013.12.023","volume":"146","author":"N Korneychuk","year":"2014","unstructured":"Korneychuk, N. et al. Interleukin 15 and CD4+ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen. Gastroenterology 146, 1017\u20131027 (2014).","journal-title":"Gastroenterology"},{"key":"895_CR73","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.molmed.2019.05.009","volume":"25","author":"A Christophersen","year":"2019","unstructured":"Christophersen, A., Risnes, L. F., Dahal-Koirala, S. & Sollid, L. M. Therapeutic and diagnostic implications of T cell scarring in celiac disease and beyond. Trends Mol. Med. 25, 836\u2013852 (2019).","journal-title":"Trends Mol. Med."},{"key":"895_CR74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/imr.12535","volume":"277","author":"L Zheng","year":"2017","unstructured":"Zheng, L., Li, J. & Lenardo, M. Restimulation-induced cell death: new medical and research perspectives. Immunol. Rev. 277, 44\u201360 (2017).","journal-title":"Immunol. Rev."},{"key":"895_CR75","doi-asserted-by":"publisher","first-page":"eaao5563","DOI":"10.1126\/scitranslmed.aao5563","volume":"11","author":"L Klotz","year":"2019","unstructured":"Klotz, L. et al. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects. Sci. Transl. Med. 11, eaao5563 (2019).","journal-title":"Sci. Transl. Med."},{"key":"895_CR76","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2858","volume":"10","author":"AW Thomson","year":"2010","unstructured":"Thomson, A. W. & Knolle, P. A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10, 753\u2013766 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"895_CR77","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","volume":"10","author":"M Zheng","year":"2019","unstructured":"Zheng, M. & Tian, Z. Liver-mediated adaptive immune tolerance. Front. Immunol. 10, 2525 (2019).","journal-title":"Front. Immunol."},{"key":"895_CR78","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41551-019-0424-1","volume":"3","author":"DS Wilson","year":"2019","unstructured":"Wilson, D. S. et al. Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes. Nat. Biomed. Eng. 3, 817\u2013829 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"895_CR79","doi-asserted-by":"publisher","first-page":"711217","DOI":"10.3389\/fimmu.2021.711217","volume":"12","author":"AG Bozward","year":"2021","unstructured":"Bozward, A. G., Ronca, V., Osei-Bordom, D. & Oo, Y. H. Gut-liver immune traffic: deciphering immune-pathogenesis to underpin translational therapy. Front. Immunol. 12, 711217 (2021).","journal-title":"Front. Immunol."},{"key":"895_CR80","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0753-3322(01)80003-2","volume":"54","author":"G Oberhuber","year":"2000","unstructured":"Oberhuber, G. Histopathology of celiac disease. Biomed. Pharmacother. 54, 368\u2013372 (2000).","journal-title":"Biomed. Pharmacother."},{"key":"895_CR81","doi-asserted-by":"publisher","unstructured":"Syage, J. A. et al. A composite morphometric duodenal biopsy mucosal scale for celiac disease encompassing both morphology and inflammation. Clin. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2023.10.031 (2023).","DOI":"10.1016\/j.cgh.2023.10.031"},{"key":"895_CR82","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/gutjnl-2012-302196","volume":"62","author":"D Leffler","year":"2013","unstructured":"Leffler, D. et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 62, 996\u20131004 (2013).","journal-title":"Gut"},{"key":"895_CR83","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/gutjnl-2017-314461","volume":"67","author":"VK Sarna","year":"2018","unstructured":"Sarna, V. K. et al. HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge. Gut 67, 1606\u20131613 (2018).","journal-title":"Gut"},{"key":"895_CR84","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","volume":"152","author":"JA Murray","year":"2017","unstructured":"Murray, J. A. et al. No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease. Gastroenterology 152, 787\u2013798.e2 (2017).","journal-title":"Gastroenterology"},{"key":"895_CR85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2032441","volume":"385","author":"D Schuppan","year":"2021","unstructured":"Schuppan, D. et al. A randomized trial of a transglutaminase 2 inhibitor for celiac disease. N. Engl. J. Med. 385, 35\u201345 (2021).","journal-title":"N. Engl. J. Med."},{"key":"895_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076163","volume":"8","author":"J Taavela","year":"2013","unstructured":"Taavela, J. et al. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS ONE 8, e76163 (2013).","journal-title":"PLoS ONE"},{"key":"895_CR87","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1053\/j.gastro.2017.06.002","volume":"153","author":"KJ Werkstetter","year":"2017","unstructured":"Werkstetter, K. J. et al. Accuracy in diagnosis of celiac disease without biopsies in clinical practice. Gastroenterology 153, 924\u2013935 (2017).","journal-title":"Gastroenterology"},{"key":"895_CR88","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13000-023-01412-x","volume":"18","author":"AM Gruver","year":"2023","unstructured":"Gruver, A. M. et al. Pathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score and dietary intervention response. Diagn. Pathol. 18, 122 (2023).","journal-title":"Diagn. Pathol."},{"key":"895_CR89","doi-asserted-by":"publisher","first-page":"2003526","DOI":"10.1002\/advs.202003526","volume":"8","author":"J Stamnaes","year":"2021","unstructured":"Stamnaes, J. et al. In well-treated celiac patients low-level mucosal inflammation predicts response to 14-day gluten challenge. Adv. Sci. 8, 2003526 (2021).","journal-title":"Adv. Sci."},{"key":"895_CR90","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.cgh.2018.04.008","volume":"16","author":"D Petroff","year":"2018","unstructured":"Petroff, D. et al. Antibody concentrations decrease 14-fold in children with celiac disease on a gluten-free diet but remain high at 3 months. Clin. Gastroenterol. Hepatol. 16, 1442\u20131449 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"895_CR91","doi-asserted-by":"publisher","first-page":"eaaw7756","DOI":"10.1126\/sciadv.aaw7756","volume":"5","author":"G Goel","year":"2019","unstructured":"Goel, G. et al. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci. Adv. 5, eaaw7756 (2019).","journal-title":"Sci. Adv."},{"key":"895_CR92","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/apt.15477","volume":"50","author":"JA Tye-Din","year":"2019","unstructured":"Tye-Din, J. A. et al. Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Aliment. Pharmacol. Ther. 50, 901\u2013910 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"895_CR93","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/73200","volume":"6","author":"RP Anderson","year":"2000","unstructured":"Anderson, R. P., Degano, P., Godkin, A. J., Jewell, D. P. & Hill, A. V. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6, 337\u2013342 (2000).","journal-title":"Nat. Med."},{"key":"895_CR94","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/gut.2004.059998","volume":"54","author":"RP Anderson","year":"2005","unstructured":"Anderson, R. P. et al. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 54, 1217\u20131223 (2005).","journal-title":"Gut"},{"key":"895_CR95","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1073\/pnas.0608610104","volume":"104","author":"M R\u00e1ki","year":"2007","unstructured":"R\u00e1ki, M. et al. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc. Natl Acad. Sci. USA 104, 2831\u20132836 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"895_CR96","doi-asserted-by":"publisher","first-page":"13073","DOI":"10.1073\/pnas.1311861110","volume":"110","author":"A Han","year":"2013","unstructured":"Han, A. et al. Dietary gluten triggers concomitant activation of CD4+ and CD8+ \u03b1\u03b2 T cells and \u03b3\u03b4 T cells in celiac disease. Proc. Natl Acad. Sci. USA 110, 13073\u201313078 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"895_CR97","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1177\/2050640619874183","volume":"7","author":"S Z\u00fchlke","year":"2019","unstructured":"Z\u00fchlke, S. et al. CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease. United European Gastroenterol. J. 7, 1337\u20131344 (2019).","journal-title":"United European Gastroenterol. J."},{"key":"895_CR98","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1053\/j.gastro.2020.10.040","volume":"160","author":"MM Leonard","year":"2021","unstructured":"Leonard, M. M. et al. Evaluating responses to gluten challenge: a randomized, double-blind, 2-dose gluten challenge trial. Gastroenterology 160, 720\u2013733.e8 (2021).","journal-title":"Gastroenterology"},{"key":"895_CR99","doi-asserted-by":"publisher","first-page":"661622","DOI":"10.3389\/fimmu.2021.661622","volume":"12","author":"MY Hardy","year":"2021","unstructured":"Hardy, M. Y. et al. A sensitive whole blood assay detects antigen-stimulated cytokine release from CD4+ T cells and facilitates immunomonitoring in a phase 2 clinical trial of Nexvax2 in coeliac disease. Front. Immunol. 12, 661622 (2021).","journal-title":"Front. Immunol."},{"key":"895_CR100","unstructured":"Adelman, D. C. Patient reported outcomes: instrument development and selection issues. US Patent application US 2015\/0223747A1 (2015)."},{"key":"895_CR101","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","volume":"148","author":"DA Leffler","year":"2015","unstructured":"Leffler, D. A. et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology 148, 1311\u20131319.e6 (2015).","journal-title":"Gastroenterology"},{"key":"895_CR102","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/apt.13703","volume":"44","author":"WJ Canestaro","year":"2016","unstructured":"Canestaro, W. J., Edwards, T. C. & Patrick, D. L. Systematic review: patient-reported outcome measures in coeliac disease for regulatory submissions. Aliment. Pharmacol. Ther. 44, 313\u2013331 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"895_CR103","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/apt.15551","volume":"51","author":"AJM Daveson","year":"2020","unstructured":"Daveson, A. J. M. et al. Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Aliment. Pharmacol. Ther. 51, 244\u2013252 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"895_CR104","doi-asserted-by":"publisher","first-page":"319","DOI":"10.14309\/ajg.0000000000001565","volume":"117","author":"AK Cartee","year":"2022","unstructured":"Cartee, A. K. et al. Plasma IL-2 and symptoms response after acute gluten exposure in subjects with celiac disease or nonceliac gluten sensitivity. Am. J. Gastroenterol. 117, 319\u2013326 (2022).","journal-title":"Am. J. Gastroenterol."},{"key":"895_CR105","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12876-023-02934-w","volume":"23","author":"I Ahonen","year":"2023","unstructured":"Ahonen, I. et al. Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease. BMC Gastroenterol. 23, 301 (2023).","journal-title":"BMC Gastroenterol."},{"key":"895_CR106","unstructured":"FDA. Celiac disease: developing drugs for adjunctive treatment to a gluten-free diet. FDA-2021-D-1238. FDA https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/celiac-disease-developing-drugs-adjunctive-treatment-gluten-free-diet (2023)."},{"key":"895_CR107","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2022.07.024","volume":"164","author":"SSCD Executive CouncilSSCD Writing Committte.","year":"2023","unstructured":"SSCD Executive Council & SSCD Writing Committte.FDA draft guidance for developing drugs for adjunctive treatment to a gluten-free diet: comments by the Society for the Study of Celiac Disease. Gastroenterology 164, 495\u2013496 (2023).","journal-title":"Gastroenterology"},{"key":"895_CR108","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.gastro.2023.08.051","volume":"166","author":"B Lebwohl","year":"2023","unstructured":"Lebwohl, B. et al. Standardizing randomized controlled trials in celiac disease: an international multidisciplinary appropriateness study. Gastroenterology 166, 88\u2013102 (2023).","journal-title":"Gastroenterology"},{"key":"895_CR109","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.it.2015.05.007","volume":"36","author":"DR Getts","year":"2015","unstructured":"Getts, D. R., Shea, L. D., Miller, S. D. & King, N. J. Harnessing nanoparticles for immune modulation. Trends Immunol. 36, 419\u2013427 (2015).","journal-title":"Trends Immunol."},{"key":"895_CR110","doi-asserted-by":"publisher","first-page":"121457","DOI":"10.1016\/j.biomaterials.2022.121457","volume":"283","author":"LM Casey","year":"2022","unstructured":"Casey, L. M. et al. Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance. Biomaterials 283, 121457 (2022).","journal-title":"Biomaterials"},{"key":"895_CR111","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1053\/j.gastro.2020.01.045","volume":"158","author":"TL Freitag","year":"2020","unstructured":"Freitag, T. L. et al. Gliadin nanoparticles induce immune tolerance to gliadin in mouse models of celiac disease. Gastroenterology 158, 1667\u20131681.e12 (2020).","journal-title":"Gastroenterology"},{"key":"895_CR112","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","volume":"161","author":"CP Kelly","year":"2021","unstructured":"Kelly, C. P. et al. TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study. Gastroenterology 161, 66\u201380.e8 (2021).","journal-title":"Gastroenterology"},{"key":"895_CR113","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/study\/NCT04530123 (2023)."},{"key":"895_CR114","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/study\/NCT05660109 (2023)."},{"key":"895_CR115","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S2468-1253(23)00107-3","volume":"8","author":"JA Murray","year":"2023","unstructured":"Murray, J. A. et al. Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial. Lancet Gastroenterol. Hepatol. 8, 735\u2013747 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"895_CR116","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/study\/NCT05574010 (2024)."},{"key":"895_CR117","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","volume":"2","author":"G Goel","year":"2017","unstructured":"Goel, G. et al. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol. Hepatol. 2, 479\u2013493 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"895_CR118","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/apt.15435","volume":"50","author":"KE Truitt","year":"2019","unstructured":"Truitt, K. E. et al. Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease. Aliment. Pharmacol. Ther. 50, 547\u2013555 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"895_CR119","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","volume":"26","author":"AJM Daveson","year":"2017","unstructured":"Daveson, A. J. M. et al. Epitope-specific immunotherapy targeting CD4-positive T cells in celiac disease: safety, pharmacokinetics, and effects on intestinal histology and plasma cytokines with escalating dose regimens of Nexvax2 in a randomized, double-blind, placebo-controlled phase 1 study. EBioMedicine 26, 78\u201390 (2017).","journal-title":"EBioMedicine"},{"key":"895_CR120","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/study\/NCT03644069 (2019)."},{"key":"895_CR121","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S2468-1253(22)00428-9","volume":"8","author":"JA Tye-Din","year":"2023","unstructured":"Tye-Din, J. A. et al. Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. Lancet Gastroenterol. Hepatol. 8, 446\u2013457 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"895_CR122","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/study\/NCT04806737 (2021)."},{"key":"895_CR123","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.4049\/jimmunol.0802891","volume":"183","author":"IL Huibregtse","year":"2009","unstructured":"Huibregtse, I. L. et al. Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J. Immunol. 183, 2390\u20132396 (2009).","journal-title":"J. Immunol."},{"key":"895_CR124","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nri2546","volume":"9","author":"AW Thomson","year":"2009","unstructured":"Thomson, A. W., Turnquist, H. R. & Raimondi, G. Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 9, 324\u2013337 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"895_CR125","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1073\/pnas.1408686111","volume":"112","author":"RA Maldonado","year":"2015","unstructured":"Maldonado, R. A. et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc. Natl Acad. Sci. USA 112, E156\u2013E165 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"895_CR126","doi-asserted-by":"publisher","first-page":"eabi9591","DOI":"10.1126\/science.abi9591","volume":"376","author":"J Li","year":"2022","unstructured":"Li, J. et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 376, eabi9591 (2022).","journal-title":"Science"},{"key":"895_CR127","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1365-2249.2000.01312.x","volume":"121","author":"AA Osman","year":"2000","unstructured":"Osman, A. A. et al. B cell epitopes of gliadin. Clin. Exp. Immunol. 121, 248\u2013254 (2000).","journal-title":"Clin. Exp. Immunol."},{"key":"895_CR128","doi-asserted-by":"publisher","first-page":"111541","DOI":"10.1016\/j.celrep.2022.111541","volume":"41","author":"C Zhou","year":"2022","unstructured":"Zhou, C. et al. Focused B cell response to recurring gluten motif with implications for epitope spreading in celiac disease. Cell Rep. 41, 111541 (2022).","journal-title":"Cell Rep."},{"key":"895_CR129","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531\u2013564 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"895_CR130","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nri.2016.111","volume":"16","author":"W Yu","year":"2016","unstructured":"Yu, W., Freeland, D. M. H. & Nadeau, K. C. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat. Rev. Immunol. 16, 751\u2013765 (2016).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-024-00895-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-024-00895-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-024-00895-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T13:01:35Z","timestamp":1714482095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-024-00895-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":130,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1038\/s41575-024-00895-3","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"assertion":[{"value":"8 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the past 3 years, the author has been a consultant for Bristol Myers Squibb, GSK, Mozart Therapeutics, Ono Pharmaceutical, Precigen ActoBio, Sanofi, SQZ Biotech, Takeda and Topas Therapeutics. He has also previously been a consultant for ImmusanT.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}